s6y

Jyong Biotech Ltd.

Ticker
MENS
CIK
1954488
Industry
Pharmaceutical Preparations

Financials 1

  1. NT 20-F Notice under Rule 12b25 of inability to timely file all or part of an annual report of form 20-F for period ending Dec 31, 2025

Ownership 7

  1. 3 Initial statement of beneficial ownership of securities
  2. 3 Initial statement of beneficial ownership of securities
  3. 3 Initial statement of beneficial ownership of securities
  4. 3 Initial statement of beneficial ownership of securities
  5. 3 Initial statement of beneficial ownership of securities
  6. 3 Initial statement of beneficial ownership of securities
  7. 3 Initial statement of beneficial ownership of securities

Prospectus 11

  1. 424B4 Prospectus filed pursuant to Rule 424(b)(4)
  2. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  3. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  4. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  5. FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
  6. RW Registration Withdrawal Request
  7. DRSLTR Correspondence Related to Draft Registration Statement
  8. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
  9. DRSLTR Correspondence Related to Draft Registration Statement
  10. DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy

All 11 prospectus filings

Other 54

  1. 20-F Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
  2. SCHEDULE 13D
  3. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  4. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  5. SP 15D2 Special Financial Report filed under Rule 15d-2
  6. 6-K Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
  7. EFFECT Notice of Effectiveness
  8. CERT Certification by an exchange approving securities for listing
  9. 8-A12B Form for the registration / listing of a class of securities on a national securities exchange pursuant to Section 12(b)
  10. CORRESP A correspondence can be sent as a document with another submission type or can be sent as a separate submission.

All 54 other filings